When people ask what drives our overall strategy at FitForMe, I could give a one word response: research. We treat it as the foundation of how we build products, how we earn trust, and how we grow, not as a cost line or a marketing tactic.
The audience that keeps us honest
Every year, we communicate with roughly 8,000 healthcare providers across the countries where we operate. These are doctors, nurses, dieticians and other clinicians seeing patients who are working through metabolic health challenges and overcoming obesity. Those providers are advising people on how to reach their long-term health goals, and they are rightly skeptical of anything that can’t back up its claims.
That skepticism is a gift. It forces us to hold our products to the standard of evidence rather than the standard of good messaging. When we engage either a patient or a clinician, we want the conversation to start from science.
It forces us to hold our products to the standard of evidence rather than the standard of good messaging.
Credibility is built over time
Over the last 20 years, we have published 21 peer-reviewed papers with research partners across Europe, and this body of work is at the core of our credibility. It is the reason a busy clinician will take our call, read our materials, and consider recommending what we make to the patients in their care.
Volume alone isn’t the point. Independence matters just as much. We work with external research partners so that our findings carry weight and aren’t dismissed as research designed to reach a convenient conclusion. Research that looks biased doesn’t just fail to persuade, it erodes the trust we’ve spent decades building. Independent partnerships protect the integrity of the science and, in turn, the value of our claims.
The problem with the traditional timeline
Here is the honest challenge: conventional research is slow. From ethics approvals through recruitment, data collection, analysis, and publication, the path can take years. In the meantime, the market moves, patient needs evolve, and customers expect us to substantiate what we offer now.
Our customers demand evidence, and they demand it faster than the traditional model can deliver. Investing in research only pays off if the evidence arrives while it can still inform decisions and support claims. That tension between rigor and speed is one the whole industry has to confront.
The ROI of research in nutrition
Research is a real investment, so it’s fair to ask what it returns. I see two answers.
First, research differentiates you with consumers who are smarter than ever. People are better informed about their own health goals, and AI is now in their toolbox. Ingredient lists that once took real expertise to interpret can be broken down by anyone in seconds. In that environment, claims without substance are easy to spot.
Brands with credible, published evidence stand apart from those relying on marketing language alone.
Second, the return arrives on different horizons, and it’s worth planning for all of them. The long-term return is the one most people expect: your brand and your scientific credibility, built study by study over years. But research also pays off sooner:
- Product development. Research helps tailor formulas more precisely and can surface new ingredients or formulations that better meet a product’s goals.
- Partnerships. Working with credible partners strengthens academic-industry collaboration, reinforces scientific credibility, and puts your work into the citation graph that AI systems draw from, shaping how your science is discovered.
Together, research becomes a compounding asset rather than a one-time expense: near-term gains in products and partnerships, and over time a reputation competitors can’t easily copy.
The takeaway
Investing in research isn’t optional for us. It’s how we earn the attention of 8,000 healthcare providers, support the 200,000 patients who take our supplements daily, and stay credible in a field where trust is everything. In our fast-moving industry, the companies that lead will treat rigorous research as strategy and find smarter, faster ways to do it.
Becky Brown is a product and marketing leader with a track record of building and scaling health technology and nutrition brands, most recently leading research and product development for FitForMe, Europe’s leading supplement company serving people affected by obesity.

